However, persistent antigen stimulation resulting from chronic hepatitis and liver diseases may lead to continuous activation of CD28 and PD-1 signaling, resulting in an antigen tolerance response in HCC (49). This evidence concerns the gene CD28 and hepatocellular carcinoma.